Document is current
Any future updates will be listed below
-
Authors
Yildirim, Hilin https://orcid.org/0000-0003-0965-7968
Bins, Adriaan D.
van den Hurk, Corina
van Moorselaar, R. Jeroen A.
van Oijen, Martijn G. H.
Bex, Axel
Zondervan, Patricia J.
Aben, Katja K. H.
- License Information
-
More Information
Article History
Received: 27 July 2023
Accepted: 6 March 2024
First Online: 13 April 2024
Declarations
:
: AB: Recipient of a restricted educational grant from Pfizer for a neoadjuvant trial (remuneration made to the employer and sponsor of the trial). Steering committee member of adjuvant trials of BMS and Roche/Genentech. No other conflicts of interests to declare by authors. No funding was received for conducting this study.
: This study was performed in line with the principles of the Declaration of Helsinki. This study was approved by the Netherlands Cancer Registry Supervisory Committee (reference number K22.346).
